Avulux
PrivateLast Round
Accelerator
Mar 24, 2025
Company Overview
Avulux is a therapeutic device company that develops and markets precision-engineered migraine and light sensitivity lenses.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, D2C Brands, Clinical Trials
Business Model
B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avulux Comparables
Compare Avulux with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TheraSpecs | 84% | |
| Sleepaxa Private Limited | 83% | |
| MigraLens | 81% | |
Avulux Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Mar 24, 2025 |
Avulux Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Consortium for Technology & Innovation in Pediatrics | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 12, 2025
Grew 27% QoQ, from 15 to 19 employees.
Avulux Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Avulux's valuation, stock price, and market status.